Business Context and Reporting Period
Company: Protagonist Therapeutics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 6, 2018
Reporting Period: Single event date (August 6, 2018)
Business Context: The registrant is an emerging growth company incorporated in Delaware. This filing serves as a Regulation FD disclosure to furnish a presentation intended for use in a conference call held on August 6, 2018.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing to disclose the existence of a presentation and does not contain audited or unaudited financial statements.
Material Changes
No material changes to financial position or operations are reported within the text of this filing. The filing solely references the attachment of a presentation (Exhibit 99.1) for a conference call.
Guidance, Outlook, and Risks
Management Commentary: The company intends to use the attached presentation (Exhibit 99.1) for a conference call on August 6, 2018.
Legal Status of Information: The information in this report, including the attached presentation, is furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. It is not subject to the liability of that section and is not incorporated by reference into other filings unless expressly stated.
Risks and Contingencies: No specific risks or contingencies are detailed in the text of this filing.
Investor Verification Checklist
- Review Exhibit 99.1 (the presentation dated August 6, 2018) for specific financial data, clinical updates, or strategic guidance not included in this summary.
- Verify the company's status as an emerging growth company and its election regarding extended transition periods for accounting standards.
- Confirm that the information in the attached presentation is not legally "filed" under Section 18 of the Exchange Act, limiting liability protections for the content.